Colleen Acosta is the founder of Freya Biosciences. Freya Biosciences has raised $50M in total funding. Latest round: Series A. Based in Copenhagen, Denmark.
Colleen Acosta is the CEO and co-founder of Freya Biosciences, a biotech company advancing women's reproductive immunotherapies targeting the vaginal microbiota. She led the company through an $8 million seed round in 2020 and a $38 million Series A in late 2023, one of the largest raises in women's reproductive immunotherapy. Acosta has emphasized translating insights from the 2014 Ebola outbreak into biotech strategies for microbiome-based fertility and women's health solutions.
Full founder directory · Investor directory · Company funding database · Fundraising library